Advancedcell biology

Amyloid Diseases: When Proteins Aggregate

Overview

Many unrelated proteins can misfold into amyloid fibrils — highly ordered cross-beta aggregates that damage tissues. This lesson covers amyloid structure, the major amyloid diseases, and therapeutic strategies.

Learning objectives

  • Describe amyloid fibril structure
  • Explain the amyloid hypothesis of Alzheimer's
  • Distinguish major amyloid diseases
  • Evaluate therapeutic approaches

What is amyloid?

Amyloid fibrils are unbranched protein aggregates with a cross-beta structure: beta-strands run perpendicular to the fibril axis. They bind Congo red (apple-green birefringence) and thioflavin T — diagnostic hallmarks.

Key idea

Cross-beta fibrils + Congo red birefringence = amyloid, regardless of the protein.

Alzheimer's disease

Amyloid-beta plaques and tau tangles characterize Alzheimer's. The amyloid hypothesis holds that Aβ aggregation initiates the cascade; genetics (APP, presenilin mutations) strongly support it. Anti-amyloid antibodies (lecanemab) modestly slow decline.

Exam tip

APP/presenilin mutations → early-onset Alzheimer's: the strongest genetic evidence for the amyloid hypothesis.

Other amyloid diseases

Parkinson's (alpha-synuclein Lewy bodies), Huntington's (polyglutamine), type 2 diabetes (amylin in pancreas), systemic AL amyloidosis (immunoglobulin light chains in organs).

Watch out

Same fibril architecture, different proteins, different organs — amyloid is a fold, not a specific protein.

Oligomers vs. fibrils

Growing evidence implicates small soluble oligomers — not the large fibrils — as the most toxic species. Fibrils may even be protective sinks sequestering toxic oligomers.

Takeaway

Toxicity likely comes from oligomers; fibrils may be the tombstones, not the killers.

Therapeutic strategies

Anti-aggregation antibodies, BACE inhibitors (reduce Aβ production), chaperone boosters, and early-intervention trials. Success has been modest — highlighting the need to treat before symptoms.

Clinical note

Lecanemab/donanemab slow decline ~25-35% in early Alzheimer's — proof of concept, not cure.

Key points

  • Amyloid = cross-beta fibrils
  • Congo red gives apple-green birefringence
  • Aβ plaques define Alzheimer's
  • Oligomers likely most toxic
  • Many proteins can form amyloid

Common misconceptions

✗ Myth: Amyloid plaques are the direct cause of Alzheimer's symptoms.

✓ Truth: Soluble oligomers correlate better with toxicity; plaques may partly be protective sequestration.

✗ Myth: Only brain proteins form amyloid.

✓ Truth: Light chains, amylin, transthyretin and others form systemic amyloid in organs throughout the body.

Practice questions

Q1. Amyloid is diagnosed histologically by:
  1. Congo red staining with apple-green birefringence
  2. Gram staining
  3. Silver staining only
  4. H&E always
Answer: A.

Congo red binding with characteristic birefringence under polarized light is the diagnostic gold standard.

Q2. In Alzheimer's, amyloid-beta derives from:
  1. APP processing by secretases
  2. Tau protein
  3. Alpha-synuclein
  4. Prion protein
Answer: A.

Beta- and gamma-secretase cleave amyloid precursor protein to release Aβ peptides.

Q3. Systemic AL amyloidosis involves aggregation of:
  1. Immunoglobulin light chains
  2. Insulin
  3. Hemoglobin
  4. Collagen
Answer: A.

Plasma cell disorders overproduce light chains that deposit as amyloid in kidneys, heart, and other organs.

Click a question to reveal the answer and explanation.

Frequently asked questions

What structural feature defines amyloid fibrils?

Cross-beta structure: beta-strands oriented perpendicular to the fibril axis, forming extremely stable hydrogen-bonded sheets. This common architecture binds Congo red and thioflavin T.

What is the amyloid hypothesis of Alzheimer's?

That accumulation of amyloid-beta initiates a cascade (tau tangles, inflammation, synaptic loss) causing dementia. Supported by APP/presenilin genetics and modest benefits of anti-amyloid antibodies.

Why might oligomers be more toxic than fibrils?

Small soluble oligomers expose hydrophobic surfaces that disrupt membranes and synapses, while large fibrils bury these surfaces — fibrils may sequester toxic species rather than cause damage directly.